TherapeuticsMD | TXMD - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -6.66B 3.39B 2026-03
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Cipla INR 344.32B 15.13B 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Novo Nordisk DKK 26.56B 111.98B 2025-06
Pfizer USD 90.1B 3.63B 2026-03
TherapeuticsMD USD 27.67M 990K 2024-06